PRKXP1 is another pseudogene; interestingly the original gene PRKX is patented as an Alzheimer’s disease diagnostic and therapeutic target (http://www.google.com/patents/US20090136504). This evidence concerns the gene PRKX and early-onset autosomal dominant Alzheimer disease.